Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuhiko Arakawa

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Digestive Diseases and Sciences|May 23, 2013
Increased expression of 5-HT3 and NK 1 receptors in 5-fluorouracil-induced mucositis in mouse jejunumKenjiro Matsumoto, Tomoharu Nakajima, Hiroyasu Sakai, et al.
Journal of Biochemistry|July 30, 2024
Sequential post-translational modifications regulate damaged DNA-binding protein DDB2 functionHidenori Kaneoka, Kazuhiko Arakawa, Yusuke Masuda, et al.
Breast Cancer Research and Treatment|November 27, 2016
Endocan as a prognostic biomarker of triple-negative breast cancerAtsunobu Sagara, Katsuhide Igarashi, Maky Otsuka, et al.
Toxicology and Applied Pharmacology|May 15, 2014
Mechanisms of cisplatin-induced muscle atrophyHiroyasu Sakai, Atsunobu Sagara, Kazuhiko Arakawa, et al.
Plos One|February 23, 2017
Chronic treatment of non-small-cell lung cancer cells with gefitinib leads to an epigenetic loss of epithelial properties associated with reductions in microRNA-155 and -200cMichiko Narita, Eri Shimura, Atsumi Nagasawa, et al.
British Journal of Cancer|August 9, 2022
Possible mechanism for improving the endogenous immune system through the blockade of peripheral μ-opioid receptors by treatment with naldemedineEizoh Gondoh, Yusuke Hamada, Tomohisa Mori, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Digestive Diseases and Sciences|May 23, 2013
Increased expression of 5-HT3 and NK 1 receptors in 5-fluorouracil-induced mucositis in mouse jejunumKenjiro Matsumoto, Tomoharu Nakajima, Hiroyasu Sakai, et al.
Journal of Biochemistry|July 30, 2024
Sequential post-translational modifications regulate damaged DNA-binding protein DDB2 functionHidenori Kaneoka, Kazuhiko Arakawa, Yusuke Masuda, et al.
Breast Cancer Research and Treatment|November 27, 2016
Endocan as a prognostic biomarker of triple-negative breast cancerAtsunobu Sagara, Katsuhide Igarashi, Maky Otsuka, et al.
Toxicology and Applied Pharmacology|May 15, 2014
Mechanisms of cisplatin-induced muscle atrophyHiroyasu Sakai, Atsunobu Sagara, Kazuhiko Arakawa, et al.
Plos One|February 23, 2017
Chronic treatment of non-small-cell lung cancer cells with gefitinib leads to an epigenetic loss of epithelial properties associated with reductions in microRNA-155 and -200cMichiko Narita, Eri Shimura, Atsumi Nagasawa, et al.
British Journal of Cancer|August 9, 2022
Possible mechanism for improving the endogenous immune system through the blockade of peripheral μ-opioid receptors by treatment with naldemedineEizoh Gondoh, Yusuke Hamada, Tomohisa Mori, et al.
Pageof 1